Navigation Links
Conatus Pharmaceuticals Appoints Daniel Ripley As Head Of Corporate Development
Date:7/17/2012

SAN DIEGO, July 17, 2012 /PRNewswire/ -- Conatus Pharmaceuticals Inc. announced today the appointment of Daniel Ripley as Head of Corporate Development, effective immediately.  Mr. Ripley will lead licensing, partnering initiatives, intellectual property analysis and act as the internal coordinator of the emricasan commercialization strategy development.

"Dan brings experience in both in-licensing and out-licensing of commercial products as well as extensive experience in partnering early-to-late stage products", said Steven J. Mento, Ph.D., President and CEO. "His varied experience in drug development transactions will be particularly important as we move forward with the development of emricasan, our first-in-class caspase inhibitor, into Phase 3 clinical trials for acute liver failure and liver fibrosis, and the related coordination of its commercialization activities".

We also want to continue our strong track record of success with collaborative drug discovery partnerships with large pharmaceutical companies, expanding the development of emricasan for disease targets other than liver disease as well as monitoring our collaboration with Abbott Laboratories in cancer," continued Dr. Mento.  "In addition, we have a leadership position in intellectual property related to programmed cell death (apoptosis) including ongoing relationships with thought leaders in the field of apoptosis and in our targeted disease areas. We possess an extensive patent portfolio comprised of over 130 issued patents including patents covering composition of matter on validated drug targets and new chemical entities (NCEs) addressing those targets, as well as broad fields of use, drug-screening assays, diagnostics and antibodies.  Dan will be involved in seeking business opportunities in each of these areas".

For more than a decade, Mr. Ripley has been involved with emerging growth life science companies in the development and execution of strate
'/>"/>

SOURCE Conatus Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... , Oct. 17, 2014 With ... Medical Affairs function has come across several challenges ... efficiently and managing globalization.  The ... LLC is dedicated to providing benchmarking and best ... Affairs Consortium is a service composed of three ...
(Date:10/17/2014)... 2014  Amgen (NASDAQ: AMGN ) today ... M.D., president of Gladstone Institutes and Gladstone,s Robert W. ... "We are pleased to welcome Dr. Sandy Williams ... Bradway , chairman and chief executive officer of Amgen. ... and his direct experience in our industry will both ...
(Date:10/17/2014)... 2014 Research and Markets  has ... Development Prospect of China Dialysis Market, 2014-2018" ... on the 2013 version, this update Report provides ... industry and the relevant effect in recent three ... segmentations. Moreover, it analyzes Chinese private-owned hemodialysis services. ...
Breaking Medicine Technology:Early Key Findings from the Medical Affairs Consortium Research 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 3Research and Development Prospect of China Dialysis Market, 2014-2018 2Research and Development Prospect of China Dialysis Market, 2014-2018 3
... Improve Quality, Reduce Hospital Stays-PHILADELPHIA, April 21 ... United States are hospitalized each year for urinary ... variability across hospitals in treatment and outcomes.The findings ... potential waste in the healthcare system and to ...
... ImQuest BioSciences and Arisyn Therapeutics jointly announced today ... Institutes of Health to support the development of ... hepatitis C virus (HCV) infection. ImQuest scientists ... action of ATI-0810 (Formerly PG301029) and a series ...
Cached Medicine Technology:Hospital Care Varies Greatly for Children with Urinary Tract Infections 2Hospital Care Varies Greatly for Children with Urinary Tract Infections 3ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent 2
(Date:10/20/2014)... October 20, 2014 T.E.N., a ... firm, announced today that William H. Murray, renowned ... 2014 ISE® Luminary Leadership Award winner. Presented annually, ... of an outstanding leader and industry practitioner for ... in advancing the information security industry. , Formerly ...
(Date:10/20/2014)... 2014 Zereana Jess-Huff, a 34-year-old mother, corporate ... on a platform to think outside the bra. She doesn’t ... position to raise awareness about women’s other lady parts. , ... You say the color pink and everybody knows what you’re ... fact that it has not been won when it comes ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 My Clients ... management software application. The new module enables easy ... receive full life-cycle quality care. , This application allows ... within their practice, attach a to-do item to a ... and even set up reoccurring reminders for follow-ups. ...
(Date:10/20/2014)... Diego, CA (PRWEB) October 20, 2014 AttorneyOne.com, ... all the latest information from the FDA on Sit ... on October 10 not to purchase or use Sit and ... Sit and Slim II is promoted as weight loss product ... Sibutramine, removed from the market in 2010 for safety reasons, ...
(Date:10/20/2014)... Rockynol Retirement Community broke ... 14. The $11 million project will include the latest ... kitchen with full-service restaurant style dining. , “We are ... class Assisted Living apartments,” said Kara Hanzie, Rockynol Executive ... quality of care and this investment is proof of ...
Breaking Medicine News(10 mins):Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 2Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 4Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:My Clients Plus Announces New Workflow Management Software 2Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Rockynol Retirement Community Expands Assisted Living Center 2
... features Charlotte Martin, Lisa Loeb, Kevin Max, Ken,Andrews, ... 18 ,Hope, Volume,One, a compilation CD with ... scheduled for release on Tuesday, June 24, 2008. ... "Wake Up," previously,unreleased songs by Kevin Herchen and ...
... June 2008 -- Research findings and innovative approaches offer ... cures for adults living with type 1 diabetes, according ... Global Research Forum in Washington D.C. , Type 1 ... destruction of insulin-producing beta cells in the pancreas. ...
... heart rate is key when heart failure, irregular heartbeat ... -- When added to heart failure, the irregular heartbeat ... , Now, an international study shows that a less ... first option for keeping patients healthy under these circumstances. ...
... Spokane benefits people living with seizures, SPOKANE, Wash., ... Run/Walk for Epilepsy to be,held this Saturday, June 21 ... The event will take place from 9:30 am - ... this event to support people,living with epilepsy," said Ryan ...
... SCA Personal Care,s Global Parent Selected for Prestigious List from a ... ... Ethisphere Institute has,selected SCA, the global parent company of SCA Personal ... Ethical Companies,list., The Ethisphere Institute -- a think-tank dedicated to ...
... The following is a,statement from Larry Minnix, AAHSA ... for nursing homes:, "AAHSA believes there should ... the non-existent. Through Quality First, we have for ... based on,reliable quality information that the public can ...
Cached Medicine News:Health News:'Hope, Volume One,' a CD benefiting Suicide Awareness Voices of Education (SAVE), to Be released on June 24, 2008 2Health News:Science, hope for adults with type 1 diabetes focus of JDRF's Annual Global Diabetes Research Forum 2Health News:Science, hope for adults with type 1 diabetes focus of JDRF's Annual Global Diabetes Research Forum 3Health News:Cardiologists Spot Best Treatment for a Deadly Duo 2Health News:Cardiologists Spot Best Treatment for a Deadly Duo 3Health News:Ethisphere Institute Names SCA to List of Top Ethical Companies 2Health News:AAHSA Statement on Nursing Home Rating System 2
... a bioresorbable implant that is used for ... This proprietary, user-friendly design, shaped like a ... into burr holes and requires no fixation ... superior mechanical strength and the scaffold architecture ...
NIVEA body Good-bye Cellulite Gel-Cream visibly reduces the appearance of cellulite....
... tubes are heparinized glass capillary ... film. These tubes are used ... blood samples for the measurement ... electrolytes (excluding lithium) and can ...
... implant is a sterile off white, moist, ... porcine collagen and its constituent elastin fibres ... implant comes ready to use in double ... impermeable to oxygen, and is sterilised by ...
Medicine Products: